Changes in serum lipid concentrations in patients with chronic hepatitis C virus positive hepatitis responsive or non-responsive to interferon therapy

被引：30

作者：

Hamamoto, S ^{[1
]}

Uchida, Y ^{[1
]}

Wada, T ^{[1
]}

Moritani, M ^{[1
]}

Sato, S ^{[1
]}

Hamamoto, N ^{[1
]}

Ishihara, S ^{[1
]}

Watanabe, M ^{[1
]}

Kinoshita, Y ^{[1
]}

机构：

[1] Shimane Med Univ, Dept Internal Med 2, Izumo, Shimane 6938501, Japan

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2005年 / 20卷 / 02期

关键词：

hepatitis C virus; interferon; total cholesterol; triglyceride;

D O I：

10.1111/j.1440-1746.2004.03526.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background: Changes in serum lipid concentrations during the administration of interferon to patients with chronic hepatitis C virus (HCV) infection have not been fully investigated. The present study was designed to compare changes in serum lipid concentrations before, during and after interferon therapy in responders and non-responders to treatment. Methods: In total, 101 patients with chronic HCV positive hepatitis were enrolled in this study. High dose interferon alpha was given on alternate days for 6 months. Six months after the end of treatment patients were assessed for the presence or absence of HCV RNA to determine the results of interferon treatment. The time courses of changes in serum lipid concentrations were measured in all patients. Results: The total cholesterol level increased gradually during and after interferon therapy, and its pattern of change coincided with that of serum cholinesterase activity. Pretreatment serum cholesterol concentrations did not differ between responders and non-responders to interferon therapy. The serum triglyceride concentration, conversely, showed a sharp increase during interferon administration and returned to its basal level after the end of treatment. Responders to interferon therapy tended to have higher pretreatment triglyceride concentrations than did non-responders. Conclusions: We clarified that serum cholesterol and triglyceride levels showed different patterns of change during interferon therapy. (C) 2004 Blackwell Publishing Asia Pty Ltd.

引用

页码：204 / 208

页数：5

共 25 条

[11] Serum cholesterol and low-density lipoprotein cholesterol levels as predictors of response to interferon therapy for chronic hepatitis C
Minuk, GY
Weinstein, S
Kaita, KD
[J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) : 761 - 762
[12] Monazahian M, 1999, J MED VIROL, V57, P223, DOI 10.1002/(SICI)1096-9071(199903)57:3<223::AID-JMV2>3.0.CO
[13] 2-4
[14] Naeem M, 2001, AM J GASTROENTEROL, V96, P2468, DOI 10.1111/j.1572-0241.2001.04055.x
[15] Poynard T, 1996, HEPATOLOGY, V24, P778
[16] Detection of the negative-strand hepatitis C virus RNA in tissues: implications for pathogenesis
Quadri, R
Rubbia-Brandt, L
Abid, K
Negro, F
[J]. ANTIVIRAL RESEARCH, 2001, 52 (02) : 161 - 171
[17] PLASMA-LIPOPROTEIN CHANGES IN HUMANS INDUCED BY INTERFERON-BETA
ROSENZWEIG, IB
WIEBE, DA
BORDEN, EC
STORER, B
SHRAGO, ES
[J]. ATHEROSCLEROSIS, 1987, 67 (2-3) : 261 - 267
[18] SAKAI S, 1996, DIG ENDOSC, V8, P293
[19] Hepatitis C virus induced hypobetalipoproteinemia:: a possible mechanism for steatosis in chronic hepatitis C
Serfaty, L
Andreani, T
Giral, P
Carbonell, N
Chazouillères, O
Poupon, R
[J]. JOURNAL OF HEPATOLOGY, 2001, 34 (03) : 428 - 434
[20] HEPATIC HEPATITIS-C VIRUS-RNA AS A PREDICTOR OF A LONG-TERM RESPONSE TO INTERFERON-ALPHA THERAPY
SHINDO, M
ARAI, K
SOKAWA, Y
OKUNO, T
[J]. ANNALS OF INTERNAL MEDICINE, 1995, 122 (08) : 586 - 591

← 1 2 3 →